In the BioHarmony Drug Report Database

"Preview" Icon

Amiloride

Midamor (amiloride) is a small molecule pharmaceutical. Amiloride was first approved as Midamor on 1982-01-01. It is used to treat ascites, cystic fibrosis, edema, heart failure, and hypertension amongst others in the USA. It is known to target acid-sensing ion channel 2, acid-sensing ion channel 1, transient receptor potential cation channel subfamily V member 2, sodium/hydrogen exchanger 5, acid-sensing ion channel 3, short transient receptor potential channel 6, transient receptor potential cation channel subfamily A member 1, polycystic kidney disease 2-like 1 protein, short transient receptor potential channel 7, gonadotropin-releasing hormone receptor, alpha-2A adrenergic receptor, sodium/hydrogen exchanger 2, sodium/hydrogen exchanger 3, sodium/hydrogen exchanger 1, and urokinase-type plasminogen activator.

 

Trade Name

 

Midamor
 

Common Name

 

amiloride
 

ChEMBL ID

 

CHEMBL945
 

Indication

 

ascites, cystic fibrosis, edema, heart failure, hypertension, hypokalemia, polyuria
 

Drug Class

 

Image (chem structure or protein)

Amiloride structure rendering